DOJ Fraud Section Deputy Addresses Internal Investigations for Pharmaceutical Companies

PRESS RELEASE: Department of Justice Fraud Section Deputy Karen Morrissette Outlines the Government's Perspective on Internal Investigations by Pharmaceutical Companies in National Audioconference
	Thursday, October 16, 2003 1:00 pm - 2:45 pm (Eastern) 12:00 pm - 1:45 pm (Central) 11:00 am - 12:45 pm (Mountain) 10:00 am - 11:45 am (Pacific) Sponsored by the Pharmaceutical Compliance Forum www.PharmaAudioconferences.com
PRESS RELEASE Contact: Paul Tunnecliff 800-684-4549 phone registration@hcconferences.com WASHINGTON DC USA -- HEALTHCARE UPDATE NEWS SERVICE(TM) - OCTOBER 9, 2003: The Pharma Congress 2003, November 12 - 14, 2003, in Washington, DC, PharmaCongress.com, announced today the scheduling of a national audioconference on The New Risk Area - Pharmaceutical Company Internal Investigations in a Post Sarbanes Oxley World on Thursday, October 16, 2003, from 1:00 pm - 2:45 pm (Eastern). FEATURED FACULTY: Mike Hercz, Esq., Litigation Counsel, Amgen, Thousand Oaks, CA Karen Morrissette, Esq., Deputy Chief, Fraud Section, United States Department of Justice, Washington, DC Robert S. Litt, Esq. Partner, Arnold & Porter, and Former Principal Associate Deputy Attorney General, United States Department of Justice, Washington, DC (Moderator) AUDIOCONFERENCE AGENDA: The Audioconference agenda is set forth in Eastern Daylight Time below: 1:00 pm Welcoming Remarks and Introduction of Faculty (Robert S. Litt, Esq.) 1:05 pm The Government's Perspective on Internal Investigations (Karen Morrissette, Esq.) DOJ's Views on the Importance of Responding to Internal Allegations of Misconduct What DOJ Expects of Corporations in Conducting Internal Investigations (addressing points in the Thompson memo) Initiating the investigation (scope and mandate) Conducting the investigation Responding to the results of the investigation Cooperation with/disclosure to the government 1:25 pm Internal Investigations: Key Issues and Best Practices (Mike Hercz, Esq. and Robert S. Litt, Esq.) When to Conduct an Internal Investigation Privilege Issues Who Should Conduct It How Should It Be Conducted: Documents and Interviews Presenting the Results Responding to Identified Problems 2:05 pm Questions and Answers 2:30 pm Audioconference Adjournment AUDIOCONFERENCE LEARNING OBJECTIVES: To describe the legal and business risks that pharmaceutical companies and individuals face in responding to allegations of wrongdoing within a company To set forth the government's emerging expectations with respect to how companies investigate and respond to allegations of internal misconduct, including the unique roles of lawyers and compliance professionals To outline in detail the key procedural and substantive steps that should be taken to protect a company's rights in investigating wrongdoing, particularly the protection of applicable privileges To provide practical insight into the mechanics of conducting an internal investigation, including the collection and review of documents, interview of witnesses, and analysis of the results To discuss a company's legal obligations with respect to responding to internal misconduct, including the imposition of discipline and the implementation of corrective action measures SPONSOR: THE PHARMACEUTICAL COMPLIANCE FORUM: The Audioconference is sponsored by the Pharmaceutical Compliance Forum (PCF). PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry, to promote effective corporate compliance programs. The organization is open to others in the industry, and has more than doubled its membership since it was founded. The members meet twice a year, for one to two days, focusing on open and informal sharing of compliance information, best practices and current developments in the field. AUDIOCONFERENCE CONTINUING EDUCATION CREDIT AVAILABLE: Only Pharma Audioconferences offer 11 types of continuing education credit that can be applied for and approved online. The Following Extensive CEs: AAPC; ACCME; ACHE; ACMPE; ACPE; AHIMA; ANCC; CISSP/SSCP; HIMSS, HCCB; MCLE; and NASBA. SAVE THE DATE FOR THE PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS: Please save the date for the upcoming Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum, November 12 - 14, 2003, in Washington, DC, www.PharmaCongress.com, featuring the following keynote faculty: Thomas Abrams, Director, Div of Drug Advertising, Marketing & Communications, US Food & Drug Administration, Rockville MD Arthur L. Caplan, Ph.D., Director, Center for Bioethics, University of Pennsylvania, Fellow, American Association for the Advancement of Science, the Hastings Center, the College of Physicians of Philadelphia, and the New York Academy of Medicine, Philadelphia, PA Dara Corrigan, Acting Principal Deputy Inspector General, Office of Inspector General, Department of health and Human Services, Washington, DC Raymond Gilmartin, Chairman, President & CEO, Merck & Co., Inc., Whitehouse Station NJ Senator Chuck Grassley (R/IA) (Invited), United States Senate, Chairman, Senate Finance Committee, Washington, DC John Guthrie, Esq., Director, Medicaid Fraud Control Unit, Office of Attorney General, Columbus, OH Peter Keisler, Esq. (Invited), Assistant Attorney General, Civil Division, United States Department of Justice, Washington, DC Thomas B. Leary, Esq., Commissioner, US Federal Trade Commission, Washington DC Michael Loucks, Esq., Chief of the Health Care Fraud Unit, Asst U.S. Attorney, US Attorney's Office for the District of Massachusetts, Boston, MA Mark B. McClellan MD, Ph.D., Commissioner, US Food & Drug Administration, Rockville MD Dennis Nally, Chairman & Sr Partner, PricewaterhouseCoopers, New York, NY Janet Rehnquist, Esq., Partner, Venable LLP, Former Inspector General, Department of Health & Human Services, Washington, DC Thomas Scully, Administrator, US Center for Medicare & Medicaid Services, Department of Health & Human Services, Washington DC James Sheehan, Esq., Chief of the Civil Div, Asst U.S. Attorney, US Attorney's Office for the Eastern District of Pennsylvania, Philadelphia PA The Honorable Tommy Thompson (Invited), Secretary, Department of Health and Human Services, Washington, DC Janet Woodcock MD, Director, Center for Drug Evaluation & Research, US Food & Drug Administration, Rockville MD AUDIOCONFERENCE REGISTRATION: The Audioconference Registration Fee is $345 per Site. No limit to number of attendees per site. You can register online at: http://www.PharmaAudioconferences.com Alternatively, you can download and print the Audioconference Registration Form from the website: http://www.pharmaaudioconferences.com/pcaudio20031016/regform.pdf The completed form can be faxed to 760-418-8084 or sent to: PharmaAudioconference Office 7790 Barberry Ave Yucca Valley CA USA 92284 FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS: Please email your request to: webmaster@PharmaAudioconferences.com.